(Q50957034)

26 March 2018

title

Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. (English)

1 reference

26 March 2018

1 reference

1 reference

Goldwater PN

1

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

26 March 2018

number of pages

4

1 reference

inferred from page(s)

published in

Vaccine

1 reference

26 March 2018

volume

15

1 reference

26 March 2018

issue

4

1 reference

26 March 2018

page(s)

353-356

1 reference

26 March 2018

Hepatitis B infection in the United States. Recent trends and future strategies for control

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

The cellular basis for lack of antibody response to hepatitis B vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900202-2

7 January 2021

10.1016/S0264-410X(96)00202-2

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

9141204

1 reference

26 March 2018